Condition
Wilson's Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Wilson's Disease clinical trials that are recruiting, at sites in 11 countries (most in France (3), China (3), United States (3)). By phase: Phase 1/2 (2), Early Phase 1 (1), Phase 3 (1). The most active sponsors are Fondation Ophtalmologique Adolphe de Rothschild (2), Prime Medicine, Inc. (2), Orphalan (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 11Countries
Newest Wilson's Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| PM577a: a one-time gene-editing therapy for Wilson disease | Phase 1/2 | New Haven, Connecticut and 3 other locations | Recruiting | Aug 5, 2026 |
| PM577a: a one-time gene-editing therapy for Wilson disease | Phase 1/2 | New Haven, Connecticut and 3 other locations | Recruiting | Aug 5, 2026 |
| One-a-day trientine for newly diagnosed Wilson's disease | Phase 3 | Denver, Colorado and 9 other locations | Recruiting | Mar 12, 2026 |
| ATP7B mRNA (DSL101) therapy for Wilson disease | Early Phase 1 | Hefei, Anhui | Recruiting | Nov 21, 2025 |
| Investigating heart issues in Wilson's Disease | — | Paris | Recruiting | Aug 9, 2022 |
| International registry for Wilson's Disease patients | — | Leuven and 15 other locations | Recruiting | Feb 15, 2022 |
| Examining copper levels in breast milk of pregnant women with Wilson's disease | — | Paris | Recruiting | Jan 10, 2022 |
| Observational study on Wilson's Disease | — | Fuzhou | Recruiting | Jul 9, 2019 |
All recruiting trials (8)
-
PM577a: a one-time gene-editing therapy for Wilson disease
This study tests PM577a, a gene-editing treatment, to see if it is safe and may help people with Wilson disease who have a p.H1069Q ATP7B mutation.
-
PM577a: a one-time gene-editing therapy for Wilson disease
This study tests PM577a, a gene-editing treatment, to see if it is safe and may help people with Wilson disease who have a p.H1069Q ATP7B mutation.
-
One-a-day trientine for newly diagnosed Wilson's disease
A new once-daily trientine formulation is being tested against d-Penicillamine as a first-line treatment for people with Wilson's disease, including both children 8 and older and adults.
-
ATP7B mRNA (DSL101) therapy for Wilson disease
This treatment will test whether one or more IV infusions of ATP7B mRNA (DSL101) are safe and help control copper in adults with genetically confirmed Wilson disease.
-
Investigating heart issues in Wilson's Disease
This study is testing how Wilson's Disease affects the heart in adults by using long-term heart monitoring to see if copper buildup causes any problems.
-
International registry for Wilson's Disease patients
This study is gathering information from people with Wilson's Disease during their regular doctor visits to better understand the disease and how patients are managing it.
-
Examining copper levels in breast milk of pregnant women with Wilson's disease
This study tests how treatment for Wilson's disease affects copper levels in the breast milk of pregnant women to ensure the health of both mom and baby during breastfeeding.
-
Observational study on Wilson's Disease
This study looks at how Wilson's Disease affects people in different ways to help improve care for patients and their families.
Related topics
Quick answers
How many Wilson's Disease clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in France (3 trials), China (3 trials), United States (3 trials), New Zealand (2 trials), Saudi Arabia (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Early Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.